H.C. Wainwright maintains Evaxion stock Buy rating, $14 target
H.C. Wainwright reaffirmed a Buy rating and a $14.00 price target on Evaxion Biotech (NASDAQ:EVAX), following the company's recent successful public offering. The stock currently trades at $2.45, down ...
Microsoft founder Bill Gates explores the making of his internal operating system in new memoir
With his 70th birthday looming on this year's horizon, Microsoft founder Bill Gates looked inward to open a window into the ...
Bill Gates shares his thoughts on vaccine backlash, Intel’s woes and Google’s antitrust battle
Although Microsoft founder Bill Gates sat down for an interview with The Associated Press to discuss his new memoir, “Source ...